Sage Journals: Discover world-class research

Abstract

Background and aims

To assess the efficacy and safety of modest blood pressure (BP) reduction with valsartan within 48 h after symptom onset in patients with acute ischemic stroke and high BP.

Methods

This was a multicenter, prospective, randomized, open-label, blinded-end-point trial. A total of 393 subjects were recruited at 28 centers and then randomly assigned in a 1:1 ratio to receive valsartan (n = 195) or no treatment (n = 198) for seven-days after presentation. The primary outcome was death or dependency, defined as a score of 3–6 on the modified Rankin Scale (mRS) at 90 days after symptom onset. Early neurological deterioration (END) within seven-days and 90-day major vascular events were also assessed.

Results

There were 372 patients who completed the 90-day follow-up. The valsartan group had 46 of 187 patients (24·6%) with a 90-day mRS 3–6, compared with 42 of 185 patients (22·6%) in the control group (odds ratio [OR], 1·11; 95% confidence interval [CI], 0·69–1·79; P = 0·667). The rate of major vascular events did not differ between groups (OR, 1·41; 95% CI, 0·44–4·49; P = 0·771). There was a significant increase of END in the valsartan group (OR, 2·43; 95% CI, 1·25–4·73; P = 0·008).

Conclusions

Early reduction of BP with valsartan did not reduce death or dependency and major vascular events at 90 days, but increased the risk of END.

Keywords

blood pressure ischemic stroke outcome

Get full access to this article

View all access options for this article.

References

International Stroke Trial Collaborative Group. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet 1997; 349: 1569–81.

Leonardi-Bee

Bath

PMW

Phillips

Sandercock

PAG

. Blood pressure and clinical outcomes in the international stroke trial. Stroke 2002; 33: 1315–20.

Qureshi

Ezzeddine

Nasar

. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med 2007; 25: 32–8.

Willmot

Leonardi-Bee

Bath

. High blood pressure in acute stroke and subsequent outcome: A systematic review. Hypertension 2004; 43: 18–24.

Stead

Gilmore

Decker

Weaver

Brown

Jr . Initial emergency department blood pressure as predictor of survival after acute ischemic stroke. Neurology 2005; 65: 1179–83.

Weiss

Beloosesky

Kenett

Grossman

. Systolic blood pressure during acute stroke is associated with functional status and long-term mortality in the elderly. Stroke 2013; 44: 2434–40.

Ishitsuka

Kamouchi

Hata

. High blood pressure after acute ischemic stroke is associated with poor clinical outcomes: Fukuoka stroke registry. Hypertension 2014; 63: 54–60.

Potter

Robinson

Ford

. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): A randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 2009; 8: 48–56.

Robinson

Potter

Ford

. Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): A prospective, randomised, open, blinded-endpoint trial. Lancet 2010; 9: 767–75.

10.

Wahlgren

MacMahon

De Keyser

Indredavik

Ryman

. Intravenous Nimodipine West European Stroke Trial (INWEST) of Nimodipine in the Treatment of Acute Ischaemic Stroke. Cerebrovasc Dis 1994; 4: 204–10.

11.

Kaste

Fogelholm

Erilä

. A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke. Stroke 1994; 25: 1348–53.

12.

Sandset

Bath

Boysen

. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): A randomised, placebo-controlled, double-blind trial. Lancet 2011; 377: 741–50.

13.

Sandset

Murray

Bath

Kjeldsen

Berge

, Scandinavian Candesartan Acute Stroke Trial Study G. Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome. Stroke 2012; 43: 2108–14.

14.

European Stroke Organisation Executive C, Committee ESOW. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457–507.

15.

Jauch

Saver

Adams

. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2013; 44: 870–947.

16.

Hong

Kang

Koo

. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol 2008; 15: 1324–31.

17.

Schrader

Luders

Kulschewski

. The ACCESS study: Evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 2003; 34: 1699–703.

18.

Geeganage

Bath

. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev 2007; (4): CD000039.

19.

Geeganage

Bath

. Vasoactive drugs for acute stroke. Cochrane Database Syst Rev 2010; (7): CD002839.

20.

Mancia

Fagard

Narkiewicz

. 2013 ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159–219.

21.

Ahmed

Nasman

Wahlgren

. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 2000; 31: 1250–5.

22.

Armario

Martin-Baranera

Ceresuela

Miguel L

. Blood pressure in the initial phase of acute ischaemic stroke: Evolution and its role as an independent prognosis factor at discharge and after 3 months of follow-up. Blood Press 2008; 17: 284–90.

23.

Powers

. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 1991; 29: 231–40.

24.

Dawson

Panerai

Potter

. Serial changes in static and dynamic cerebral autoregulation after acute ischaemic stroke. Cerebrovasc Dis 2003; 16: 69–75.

25.

Powers

Videen

Diringer

Aiyagari

Zazulia

. Autoregulation after ischaemic stroke. J Hypertens 2009; 27: 2218–22.

26.

Rothwell

Howard

Spence

. Carotid Endarterectomy Trialists C. Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 2003; 34: 2583–90.

27.

Qureshi

. Acute hypertensive response in patients with stroke: Pathophysiology and management. Circulation 2008; 118: 176–87.

28.

Zhang

. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: The CATIS randomized clinical trial. JAMA 2014; 311: 479–89.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.34 MB

0.00 MB

Modest Blood Pressure Reduction with Valsartan in Acute Ischemic Stroke: A Prospective,Randomized,Open-Label,Blinded-End-Point Trial

Abstract

Background and aims

Methods

Results

Conclusions

Keywords

Get full access to this article

References

Supplementary Material